Alan Tackett
Concepts (575)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histones | 33 | 2023 | 335 | 5.810 |
Why?
| Melanoma | 12 | 2024 | 313 | 4.240 |
Why?
| Proteomics | 21 | 2023 | 343 | 3.900 |
Why?
| Saccharomyces cerevisiae Proteins | 21 | 2019 | 170 | 3.790 |
Why?
| Saccharomyces cerevisiae | 18 | 2019 | 218 | 3.020 |
Why?
| Mass Spectrometry | 23 | 2021 | 313 | 2.860 |
Why?
| Chromatin | 17 | 2023 | 156 | 2.840 |
Why?
| Protein Processing, Post-Translational | 14 | 2020 | 183 | 2.310 |
Why?
| Proteome | 12 | 2024 | 178 | 2.210 |
Why?
| Chromosomal Proteins, Non-Histone | 7 | 2021 | 44 | 1.620 |
Why?
| Protein Interaction Mapping | 4 | 2020 | 44 | 1.210 |
Why?
| Nuclear Proteins | 7 | 2017 | 252 | 1.020 |
Why?
| Histone Demethylases | 4 | 2014 | 15 | 0.980 |
Why?
| Skin Neoplasms | 4 | 2020 | 532 | 0.970 |
Why?
| Lysine | 6 | 2023 | 102 | 0.940 |
Why?
| Immunotherapy | 4 | 2021 | 263 | 0.940 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2023 | 250 | 0.930 |
Why?
| Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 74 | 0.920 |
Why?
| Animals | 50 | 2024 | 14385 | 0.870 |
Why?
| Transcription Factors | 12 | 2023 | 622 | 0.860 |
Why?
| Melanoma, Experimental | 2 | 2021 | 49 | 0.850 |
Why?
| Mice | 33 | 2023 | 6413 | 0.850 |
Why?
| Drug Resistance, Neoplasm | 3 | 2020 | 309 | 0.830 |
Why?
| CTLA-4 Antigen | 2 | 2021 | 29 | 0.810 |
Why?
| Cadherins | 2 | 2019 | 72 | 0.790 |
Why?
| Bacterial Proteins | 7 | 2020 | 454 | 0.780 |
Why?
| Histone Code | 2 | 2020 | 32 | 0.780 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 62 | 0.750 |
Why?
| Neoplasms | 7 | 2021 | 1315 | 0.750 |
Why?
| Genetic Loci | 3 | 2015 | 58 | 0.730 |
Why?
| Epigenesis, Genetic | 9 | 2023 | 399 | 0.730 |
Why?
| Neoplasms, Experimental | 1 | 2020 | 115 | 0.730 |
Why?
| Gene Expression Regulation, Fungal | 5 | 2019 | 58 | 0.730 |
Why?
| DNA-Binding Proteins | 8 | 2021 | 462 | 0.710 |
Why?
| Gene Expression Regulation, Neoplastic | 9 | 2021 | 866 | 0.710 |
Why?
| Histone Acetyltransferases | 5 | 2014 | 22 | 0.700 |
Why?
| Immunohistochemistry | 3 | 2020 | 1089 | 0.690 |
Why?
| Integrin alpha Chains | 1 | 2019 | 10 | 0.690 |
Why?
| Arsenic | 1 | 2019 | 21 | 0.680 |
Why?
| Cell Cycle Checkpoints | 1 | 2019 | 35 | 0.670 |
Why?
| Gene Silencing | 5 | 2023 | 129 | 0.640 |
Why?
| Protein Binding | 20 | 2021 | 736 | 0.640 |
Why?
| Cell Line, Tumor | 13 | 2023 | 1550 | 0.630 |
Why?
| Antigens, CD | 1 | 2019 | 242 | 0.610 |
Why?
| Tumor Escape | 1 | 2017 | 21 | 0.610 |
Why?
| Immunologic Surveillance | 1 | 2017 | 14 | 0.610 |
Why?
| Apoptosis | 11 | 2023 | 1300 | 0.600 |
Why?
| Staphylococcus aureus | 5 | 2020 | 361 | 0.600 |
Why?
| Humans | 58 | 2023 | 54246 | 0.600 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2017 | 40 | 0.590 |
Why?
| Blood Proteins | 1 | 2017 | 100 | 0.580 |
Why?
| Tumor Microenvironment | 4 | 2022 | 209 | 0.560 |
Why?
| Chromatin Immunoprecipitation | 4 | 2012 | 55 | 0.550 |
Why?
| Whole-Body Irradiation | 1 | 2017 | 160 | 0.550 |
Why?
| Chromatography, Affinity | 2 | 2012 | 50 | 0.540 |
Why?
| Up-Regulation | 3 | 2018 | 508 | 0.540 |
Why?
| Space Flight | 3 | 2020 | 37 | 0.530 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2015 | 27 | 0.520 |
Why?
| DNA-Activated Protein Kinase | 1 | 2015 | 23 | 0.520 |
Why?
| Proto-Oncogene Proteins c-ret | 1 | 2015 | 35 | 0.520 |
Why?
| Chemical Fractionation | 1 | 2015 | 18 | 0.520 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2012 | 79 | 0.500 |
Why?
| Methylation | 10 | 2023 | 130 | 0.490 |
Why?
| Repressor Proteins | 4 | 2019 | 165 | 0.480 |
Why?
| DNA | 6 | 2023 | 581 | 0.480 |
Why?
| Antineoplastic Agents | 6 | 2023 | 1300 | 0.480 |
Why?
| Cell Cycle Proteins | 6 | 2021 | 199 | 0.480 |
Why?
| Membrane Proteins | 2 | 2020 | 389 | 0.480 |
Why?
| Peptide Hydrolases | 3 | 2020 | 67 | 0.450 |
Why?
| Virulence Factors | 4 | 2020 | 92 | 0.450 |
Why?
| Thyroid Neoplasms | 1 | 2015 | 162 | 0.450 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 151 | 0.450 |
Why?
| Lung Neoplasms | 1 | 2019 | 642 | 0.440 |
Why?
| Pancreatic Neoplasms | 1 | 2015 | 234 | 0.430 |
Why?
| Nevus, Pigmented | 2 | 2012 | 37 | 0.430 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 562 | 0.420 |
Why?
| Amino Acid Sequence | 11 | 2014 | 767 | 0.420 |
Why?
| T-Lymphocytes | 3 | 2020 | 373 | 0.410 |
Why?
| Epistasis, Genetic | 2 | 2009 | 42 | 0.410 |
Why?
| Radiation, Ionizing | 3 | 2017 | 120 | 0.410 |
Why?
| Viral Nonstructural Proteins | 3 | 2008 | 61 | 0.400 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2021 | 39 | 0.400 |
Why?
| Molecular Sequence Data | 10 | 2014 | 980 | 0.390 |
Why?
| Promoter Regions, Genetic | 5 | 2023 | 520 | 0.390 |
Why?
| DNA Methylation | 5 | 2023 | 574 | 0.380 |
Why?
| DNA Helicases | 4 | 2012 | 132 | 0.380 |
Why?
| Cell Proliferation | 7 | 2023 | 1096 | 0.370 |
Why?
| Galactokinase | 3 | 2015 | 10 | 0.360 |
Why?
| Exosomes | 2 | 2021 | 45 | 0.360 |
Why?
| Chromosome Positioning | 1 | 2009 | 2 | 0.360 |
Why?
| Trans-Activators | 2 | 2020 | 147 | 0.340 |
Why?
| Protein Kinase Inhibitors | 2 | 2021 | 216 | 0.340 |
Why?
| Proteins | 2 | 2018 | 376 | 0.340 |
Why?
| Multiple Myeloma | 3 | 2023 | 3035 | 0.330 |
Why?
| Oligonucleotides | 2 | 2008 | 76 | 0.330 |
Why?
| Long Interspersed Nucleotide Elements | 3 | 2017 | 41 | 0.330 |
Why?
| Colonic Neoplasms | 2 | 2021 | 164 | 0.330 |
Why?
| DNA Replication | 2 | 2010 | 152 | 0.330 |
Why?
| Formaldehyde | 3 | 2015 | 49 | 0.320 |
Why?
| Chromatin Assembly and Disassembly | 4 | 2021 | 27 | 0.320 |
Why?
| Brain Neoplasms | 2 | 2022 | 284 | 0.310 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 3 | 2016 | 18 | 0.300 |
Why?
| Neoplasm Proteins | 3 | 2016 | 359 | 0.290 |
Why?
| Osteomyelitis | 2 | 2019 | 122 | 0.290 |
Why?
| Neoplasm Metastasis | 3 | 2016 | 252 | 0.290 |
Why?
| Homologous Recombination | 2 | 2018 | 43 | 0.290 |
Why?
| Virulence | 5 | 2020 | 194 | 0.290 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 182 | 0.290 |
Why?
| Acetylation | 8 | 2021 | 99 | 0.280 |
Why?
| Retroelements | 2 | 2023 | 15 | 0.280 |
Why?
| HEK293 Cells | 7 | 2021 | 245 | 0.280 |
Why?
| Xenopus Proteins | 2 | 2019 | 29 | 0.280 |
Why?
| Protein Structure, Tertiary | 8 | 2014 | 289 | 0.280 |
Why?
| Nuclear Pore Complex Proteins | 2 | 2021 | 9 | 0.270 |
Why?
| Disease Progression | 5 | 2023 | 913 | 0.270 |
Why?
| Viral Proteins | 2 | 2009 | 158 | 0.260 |
Why?
| Transcription, Genetic | 4 | 2009 | 418 | 0.260 |
Why?
| DNA, Single-Stranded | 2 | 2005 | 73 | 0.260 |
Why?
| Nerve Tissue Proteins | 3 | 2019 | 199 | 0.260 |
Why?
| Co-Repressor Proteins | 2 | 2023 | 17 | 0.260 |
Why?
| Phosphorylation | 6 | 2017 | 614 | 0.250 |
Why?
| Mice, Inbred C57BL | 9 | 2021 | 1999 | 0.250 |
Why?
| Proteolysis | 2 | 2022 | 102 | 0.250 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2022 | 99 | 0.240 |
Why?
| Signal Transduction | 5 | 2020 | 1753 | 0.240 |
Why?
| Gene Expression Regulation, Bacterial | 5 | 2020 | 244 | 0.240 |
Why?
| Endothelial Cells | 3 | 2021 | 294 | 0.240 |
Why?
| Antigen Presentation | 1 | 2023 | 28 | 0.240 |
Why?
| Disease Models, Animal | 5 | 2021 | 1639 | 0.240 |
Why?
| Endogenous Retroviruses | 1 | 2023 | 7 | 0.240 |
Why?
| Staphylococcal Infections | 4 | 2020 | 300 | 0.240 |
Why?
| Tumor Cells, Cultured | 3 | 2021 | 477 | 0.230 |
Why?
| Polyporaceae | 1 | 2023 | 3 | 0.230 |
Why?
| Workflow | 2 | 2020 | 57 | 0.230 |
Why?
| Methionine | 1 | 2024 | 146 | 0.220 |
Why?
| Ikaros Transcription Factor | 1 | 2022 | 6 | 0.220 |
Why?
| Weightlessness | 2 | 2020 | 14 | 0.220 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 153 | 0.210 |
Why?
| High-Throughput Screening Assays | 2 | 2013 | 37 | 0.210 |
Why?
| Peptide Nucleic Acids | 1 | 2002 | 17 | 0.210 |
Why?
| Cytochrome P-450 CYP2E1 | 2 | 2017 | 105 | 0.210 |
Why?
| Hepacivirus | 3 | 2008 | 127 | 0.210 |
Why?
| Homeodomain Proteins | 2 | 2021 | 82 | 0.210 |
Why?
| Induced Pluripotent Stem Cells | 1 | 2022 | 44 | 0.210 |
Why?
| DNA Breaks, Double-Stranded | 3 | 2017 | 78 | 0.210 |
Why?
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2023 | 108 | 0.210 |
Why?
| Breast Neoplasms | 3 | 2016 | 1248 | 0.200 |
Why?
| Phosphofructokinase-1, Type C | 1 | 2021 | 4 | 0.200 |
Why?
| YY1 Transcription Factor | 1 | 2021 | 7 | 0.200 |
Why?
| Ribonucleoproteins | 2 | 2019 | 20 | 0.200 |
Why?
| Polycomb-Group Proteins | 1 | 2021 | 9 | 0.200 |
Why?
| Spectrum Analysis, Raman | 1 | 2021 | 68 | 0.200 |
Why?
| Cell Line | 7 | 2023 | 1153 | 0.200 |
Why?
| Fungal Proteins | 3 | 2018 | 134 | 0.200 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2021 | 21 | 0.200 |
Why?
| Glioblastoma | 1 | 2022 | 99 | 0.190 |
Why?
| Gene Expression Profiling | 3 | 2023 | 1138 | 0.190 |
Why?
| Open Reading Frames | 4 | 2014 | 55 | 0.190 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 101 | 0.190 |
Why?
| Aging | 2 | 2016 | 784 | 0.190 |
Why?
| Histone-Lysine N-Methyltransferase | 2 | 2014 | 58 | 0.190 |
Why?
| Blood-Brain Barrier | 1 | 2020 | 59 | 0.190 |
Why?
| Cluster Analysis | 2 | 2019 | 249 | 0.190 |
Why?
| Mutation | 8 | 2020 | 1501 | 0.180 |
Why?
| Dose-Response Relationship, Radiation | 2 | 2017 | 204 | 0.180 |
Why?
| Neovascularization, Pathologic | 1 | 2021 | 168 | 0.180 |
Why?
| Cells, Cultured | 5 | 2018 | 1737 | 0.180 |
Why?
| Nucleosomes | 4 | 2013 | 22 | 0.180 |
Why?
| Adaptation, Ocular | 1 | 2019 | 4 | 0.180 |
Why?
| Blood-Retinal Barrier | 1 | 2019 | 6 | 0.180 |
Why?
| Poly(A)-Binding Proteins | 1 | 2019 | 6 | 0.180 |
Why?
| Phosphoproteins | 1 | 2020 | 116 | 0.180 |
Why?
| Malpractice | 1 | 2019 | 16 | 0.180 |
Why?
| Time Factors | 5 | 2017 | 3212 | 0.180 |
Why?
| Hematopoietic Stem Cells | 2 | 2021 | 215 | 0.180 |
Why?
| Translocation, Genetic | 1 | 2021 | 287 | 0.180 |
Why?
| Arsenate Reductases | 1 | 2019 | 5 | 0.170 |
Why?
| Genome, Fungal | 3 | 2010 | 43 | 0.170 |
Why?
| Models, Molecular | 5 | 2013 | 423 | 0.170 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 16 | 0.170 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2019 | 50 | 0.170 |
Why?
| Chromatography, Liquid | 3 | 2020 | 243 | 0.170 |
Why?
| Cell Cycle | 4 | 2019 | 275 | 0.170 |
Why?
| RNA-Binding Proteins | 3 | 2019 | 136 | 0.170 |
Why?
| Ruminococcus | 1 | 2019 | 9 | 0.170 |
Why?
| Protein Kinases | 1 | 2019 | 89 | 0.170 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2021 | 191 | 0.170 |
Why?
| Male | 17 | 2021 | 27312 | 0.170 |
Why?
| Muscles | 2 | 2016 | 114 | 0.170 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 124 | 0.170 |
Why?
| Diagnostic Errors | 1 | 2019 | 74 | 0.170 |
Why?
| Gravity, Altered | 1 | 2018 | 3 | 0.170 |
Why?
| Mutation Rate | 1 | 2018 | 40 | 0.170 |
Why?
| Membrane Transport Proteins | 1 | 2019 | 57 | 0.170 |
Why?
| Lipopolysaccharides | 1 | 2019 | 199 | 0.170 |
Why?
| Cecum | 1 | 2019 | 72 | 0.170 |
Why?
| Starch | 1 | 2019 | 33 | 0.170 |
Why?
| Bacteriophage T4 | 2 | 2009 | 23 | 0.170 |
Why?
| Myocytes, Cardiac | 1 | 2019 | 137 | 0.160 |
Why?
| Transcriptional Activation | 4 | 2021 | 134 | 0.160 |
Why?
| Adenosine | 1 | 2018 | 71 | 0.160 |
Why?
| Computational Biology | 1 | 2020 | 231 | 0.160 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 116 | 0.160 |
Why?
| Retina | 1 | 2018 | 64 | 0.160 |
Why?
| Models, Chemical | 3 | 2010 | 65 | 0.160 |
Why?
| Transcriptional Elongation Factors | 2 | 2009 | 28 | 0.160 |
Why?
| Chromans | 1 | 2018 | 62 | 0.160 |
Why?
| Genomics | 2 | 2013 | 310 | 0.160 |
Why?
| Oxidative Stress | 2 | 2020 | 958 | 0.160 |
Why?
| Software | 1 | 2020 | 296 | 0.150 |
Why?
| Mentors | 1 | 2018 | 56 | 0.150 |
Why?
| Interleukin-2 | 1 | 2017 | 75 | 0.150 |
Why?
| Protein Biosynthesis | 3 | 2019 | 273 | 0.150 |
Why?
| Spleen | 1 | 2018 | 186 | 0.150 |
Why?
| Scavenger Receptors, Class E | 1 | 2019 | 217 | 0.150 |
Why?
| Vitamin E | 1 | 2018 | 107 | 0.150 |
Why?
| Muscle Development | 2 | 2014 | 25 | 0.150 |
Why?
| Immunomodulation | 1 | 2017 | 42 | 0.150 |
Why?
| Cell Differentiation | 5 | 2021 | 720 | 0.150 |
Why?
| Macaca mulatta | 1 | 2017 | 106 | 0.150 |
Why?
| Universities | 1 | 2018 | 164 | 0.150 |
Why?
| Tetrahymena thermophila | 2 | 2014 | 3 | 0.150 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2017 | 53 | 0.150 |
Why?
| Gamma Rays | 1 | 2017 | 56 | 0.150 |
Why?
| Program Development | 1 | 2018 | 199 | 0.150 |
Why?
| Sequence Homology, Amino Acid | 2 | 2015 | 180 | 0.150 |
Why?
| Gene Expression Regulation | 4 | 2019 | 1062 | 0.150 |
Why?
| Myocardial Infarction | 1 | 2021 | 424 | 0.150 |
Why?
| Myogenin | 2 | 2014 | 6 | 0.150 |
Why?
| 3' Untranslated Regions | 1 | 2016 | 57 | 0.150 |
Why?
| Butadienes | 1 | 2017 | 50 | 0.140 |
Why?
| Lymphocyte Activation | 1 | 2017 | 197 | 0.140 |
Why?
| Mitochondria, Liver | 1 | 2017 | 86 | 0.140 |
Why?
| Radiation Injuries | 1 | 2018 | 153 | 0.140 |
Why?
| Calcineurin | 1 | 2017 | 70 | 0.140 |
Why?
| Protozoan Proteins | 2 | 2014 | 31 | 0.140 |
Why?
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.140 |
Why?
| Oocytes | 2 | 2019 | 94 | 0.140 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2016 | 9 | 0.140 |
Why?
| Mitochondrial Proteins | 2 | 2018 | 121 | 0.140 |
Why?
| Dose-Response Relationship, Drug | 4 | 2020 | 1476 | 0.140 |
Why?
| Mitochondria | 1 | 2020 | 489 | 0.140 |
Why?
| Mice, Inbred BALB C | 3 | 2021 | 368 | 0.140 |
Why?
| Kinetics | 4 | 2010 | 692 | 0.140 |
Why?
| Biofilms | 4 | 2020 | 200 | 0.140 |
Why?
| Adenine | 1 | 2016 | 44 | 0.140 |
Why?
| Alcohol Drinking | 1 | 2018 | 259 | 0.140 |
Why?
| Peptide Fragments | 3 | 2013 | 242 | 0.140 |
Why?
| Cell Movement | 1 | 2017 | 271 | 0.140 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 48 | 0.140 |
Why?
| Epigenomics | 1 | 2016 | 67 | 0.140 |
Why?
| Autoantigens | 1 | 2016 | 64 | 0.140 |
Why?
| Tumor Burden | 1 | 2016 | 142 | 0.140 |
Why?
| Rhadinovirus | 1 | 2015 | 15 | 0.140 |
Why?
| Ethanol | 1 | 2018 | 322 | 0.140 |
Why?
| Caenorhabditis elegans | 1 | 2016 | 146 | 0.140 |
Why?
| Antigens, Viral | 1 | 2015 | 58 | 0.130 |
Why?
| Macromolecular Substances | 2 | 2005 | 47 | 0.130 |
Why?
| Proto-Oncogene Proteins c-myb | 1 | 2015 | 9 | 0.130 |
Why?
| Chromosomes, Fungal | 2 | 2012 | 17 | 0.130 |
Why?
| Carcinogens | 1 | 2017 | 231 | 0.130 |
Why?
| Endoplasmic Reticulum | 1 | 2016 | 123 | 0.130 |
Why?
| Kidney | 1 | 2020 | 820 | 0.130 |
Why?
| Cell Survival | 5 | 2019 | 657 | 0.130 |
Why?
| Mitosis | 2 | 2013 | 106 | 0.130 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 206 | 0.130 |
Why?
| Heterochromatin | 1 | 2014 | 6 | 0.130 |
Why?
| Biomedical Research | 1 | 2018 | 240 | 0.130 |
Why?
| Collagen | 1 | 2016 | 223 | 0.130 |
Why?
| Carcinoma, Merkel Cell | 1 | 2015 | 47 | 0.130 |
Why?
| Curriculum | 1 | 2018 | 429 | 0.130 |
Why?
| Virus Replication | 1 | 2015 | 143 | 0.130 |
Why?
| Phenelzine | 1 | 2014 | 4 | 0.120 |
Why?
| Hippocampus | 1 | 2016 | 242 | 0.120 |
Why?
| Cell Culture Techniques | 1 | 2015 | 112 | 0.120 |
Why?
| Host-Pathogen Interactions | 1 | 2015 | 143 | 0.120 |
Why?
| Rhabdomyosarcoma | 1 | 2014 | 13 | 0.120 |
Why?
| T-Box Domain Proteins | 1 | 2014 | 14 | 0.120 |
Why?
| Liver | 2 | 2018 | 1225 | 0.120 |
Why?
| Threonine | 1 | 2013 | 17 | 0.120 |
Why?
| G-Quadruplexes | 1 | 2015 | 81 | 0.120 |
Why?
| Prognosis | 1 | 2019 | 2118 | 0.120 |
Why?
| Heart | 1 | 2016 | 360 | 0.120 |
Why?
| Enhancer Elements, Genetic | 3 | 2021 | 64 | 0.120 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2013 | 24 | 0.110 |
Why?
| Models, Biological | 3 | 2012 | 823 | 0.110 |
Why?
| Macaca | 1 | 2012 | 7 | 0.110 |
Why?
| Sarcoma | 1 | 2014 | 73 | 0.110 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2012 | 9 | 0.110 |
Why?
| Female | 13 | 2021 | 28418 | 0.110 |
Why?
| Sirtuin 1 | 1 | 2012 | 29 | 0.110 |
Why?
| Indoles | 1 | 2015 | 289 | 0.110 |
Why?
| DNA Repair Enzymes | 1 | 2012 | 50 | 0.110 |
Why?
| Proto-Oncogene Proteins c-mos | 1 | 2012 | 9 | 0.110 |
Why?
| Treatment Outcome | 2 | 2020 | 5604 | 0.110 |
Why?
| Brain | 1 | 2020 | 1387 | 0.100 |
Why?
| gp100 Melanoma Antigen | 1 | 2011 | 9 | 0.100 |
Why?
| Fixatives | 1 | 2011 | 13 | 0.100 |
Why?
| Alzheimer Disease | 1 | 2016 | 367 | 0.100 |
Why?
| Tissue Fixation | 1 | 2011 | 35 | 0.100 |
Why?
| Paraffin Embedding | 1 | 2011 | 56 | 0.100 |
Why?
| Enzyme Inhibitors | 1 | 2014 | 446 | 0.100 |
Why?
| MAP Kinase Signaling System | 1 | 2012 | 133 | 0.100 |
Why?
| Oncogene Proteins, Fusion | 2 | 2021 | 60 | 0.100 |
Why?
| Mice, Knockout | 3 | 2021 | 926 | 0.100 |
Why?
| Cell Transformation, Neoplastic | 2 | 2023 | 200 | 0.100 |
Why?
| Bone Neoplasms | 1 | 2013 | 193 | 0.100 |
Why?
| Escherichia coli | 2 | 2014 | 250 | 0.100 |
Why?
| Hypertension | 1 | 2016 | 563 | 0.090 |
Why?
| Diet, High-Fat | 1 | 2012 | 216 | 0.090 |
Why?
| Wnt Signaling Pathway | 2 | 2023 | 94 | 0.090 |
Why?
| Mycobacterium smegmatis | 1 | 2010 | 3 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 475 | 0.090 |
Why?
| Sugar Phosphates | 1 | 2010 | 3 | 0.090 |
Why?
| Trehalose | 1 | 2010 | 6 | 0.090 |
Why?
| Maltose | 1 | 2010 | 4 | 0.090 |
Why?
| Hexosyltransferases | 1 | 2010 | 11 | 0.090 |
Why?
| Neurons | 1 | 2014 | 486 | 0.090 |
Why?
| Glycogen | 1 | 2010 | 45 | 0.090 |
Why?
| Chromatography | 2 | 2008 | 16 | 0.090 |
Why?
| Adenosine Triphosphatases | 3 | 2008 | 90 | 0.090 |
Why?
| Protein Stability | 2 | 2020 | 44 | 0.090 |
Why?
| Movement | 1 | 2010 | 111 | 0.090 |
Why?
| Molecular Chaperones | 1 | 2009 | 64 | 0.090 |
Why?
| DNA Repair | 3 | 2017 | 202 | 0.090 |
Why?
| Peptides | 2 | 2013 | 276 | 0.090 |
Why?
| RNA, Messenger | 3 | 2019 | 1202 | 0.090 |
Why?
| Peptide Mapping | 1 | 2008 | 22 | 0.080 |
Why?
| Histone Deacetylases | 2 | 2023 | 47 | 0.080 |
Why?
| Recombinant Fusion Proteins | 1 | 2009 | 206 | 0.080 |
Why?
| RNA Helicases | 1 | 2008 | 31 | 0.080 |
Why?
| Mice, SCID | 2 | 2021 | 196 | 0.080 |
Why?
| Sequence Alignment | 3 | 2014 | 146 | 0.080 |
Why?
| Microtubules | 1 | 2008 | 57 | 0.080 |
Why?
| bcl-2-Associated X Protein | 1 | 2008 | 73 | 0.080 |
Why?
| bcl-X Protein | 1 | 2008 | 61 | 0.080 |
Why?
| DNA-Directed RNA Polymerases | 1 | 2008 | 25 | 0.080 |
Why?
| HeLa Cells | 3 | 2021 | 291 | 0.080 |
Why?
| DNA Primers | 1 | 2008 | 225 | 0.080 |
Why?
| Substrate Specificity | 3 | 2015 | 209 | 0.080 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2020 | 219 | 0.080 |
Why?
| Recombinant Proteins | 3 | 2018 | 569 | 0.080 |
Why?
| Tandem Mass Spectrometry | 2 | 2018 | 248 | 0.070 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 21 | 0.070 |
Why?
| Rats | 3 | 2019 | 3415 | 0.070 |
Why?
| Meiosis | 2 | 2018 | 70 | 0.070 |
Why?
| MCF-7 Cells | 2 | 2016 | 79 | 0.070 |
Why?
| Gene Knockdown Techniques | 2 | 2016 | 125 | 0.070 |
Why?
| E1A-Associated p300 Protein | 1 | 2006 | 8 | 0.070 |
Why?
| Binding Sites | 3 | 2014 | 440 | 0.070 |
Why?
| Mutagenesis, Site-Directed | 2 | 2021 | 117 | 0.070 |
Why?
| Nuclear Pore | 1 | 2005 | 1 | 0.070 |
Why?
| Xenopus laevis | 2 | 2019 | 49 | 0.070 |
Why?
| RNA Interference | 2 | 2016 | 195 | 0.070 |
Why?
| Staphylococcal Protein A | 1 | 2005 | 7 | 0.070 |
Why?
| Reactive Oxygen Species | 2 | 2018 | 491 | 0.070 |
Why?
| Trypsin | 1 | 2005 | 17 | 0.070 |
Why?
| DNA Polymerase II | 1 | 2005 | 10 | 0.070 |
Why?
| Acetyltransferases | 1 | 2005 | 23 | 0.070 |
Why?
| Proto-Oncogenes | 1 | 2005 | 29 | 0.070 |
Why?
| Osteoclasts | 2 | 2020 | 469 | 0.070 |
Why?
| Osteoblasts | 2 | 2020 | 514 | 0.070 |
Why?
| Phenotype | 2 | 2020 | 820 | 0.070 |
Why?
| Protein Denaturation | 1 | 2005 | 14 | 0.070 |
Why?
| Flow Cytometry | 1 | 2008 | 546 | 0.070 |
Why?
| Amino Acid Motifs | 2 | 2020 | 57 | 0.060 |
Why?
| Spectrometry, Fluorescence | 1 | 2005 | 53 | 0.060 |
Why?
| Mammals | 2 | 2016 | 57 | 0.060 |
Why?
| RNA, Viral | 1 | 2005 | 141 | 0.060 |
Why?
| Mutation, Missense | 2 | 2018 | 117 | 0.060 |
Why?
| Terminal Repeat Sequences | 1 | 2023 | 10 | 0.060 |
Why?
| S-Adenosylmethionine | 1 | 2024 | 56 | 0.060 |
Why?
| Major Histocompatibility Complex | 1 | 2023 | 14 | 0.060 |
Why?
| Microscopy, Fluorescence | 1 | 2005 | 198 | 0.060 |
Why?
| Interferons | 1 | 2023 | 44 | 0.060 |
Why?
| Gene Deletion | 2 | 2015 | 293 | 0.060 |
Why?
| Transfection | 2 | 2016 | 399 | 0.060 |
Why?
| MyoD Protein | 2 | 2014 | 11 | 0.060 |
Why?
| RNA | 1 | 2005 | 202 | 0.060 |
Why?
| Histocompatibility Antigens Class I | 1 | 2023 | 52 | 0.060 |
Why?
| Evolution, Molecular | 2 | 2016 | 103 | 0.060 |
Why?
| Tamoxifen | 1 | 2023 | 60 | 0.060 |
Why?
| HLA Antigens | 1 | 2023 | 55 | 0.060 |
Why?
| Mycelium | 1 | 2023 | 3 | 0.060 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 474 | 0.060 |
Why?
| Homocysteine | 1 | 2024 | 126 | 0.060 |
Why?
| Trametes | 1 | 2023 | 5 | 0.060 |
Why?
| Integrin beta Chains | 1 | 2023 | 14 | 0.060 |
Why?
| Genome | 1 | 2023 | 74 | 0.060 |
Why?
| Integrins | 1 | 2023 | 36 | 0.060 |
Why?
| Active Transport, Cell Nucleus | 2 | 2017 | 45 | 0.060 |
Why?
| Cytogenetic Analysis | 1 | 2023 | 90 | 0.060 |
Why?
| Young Adult | 3 | 2018 | 4308 | 0.060 |
Why?
| Monensin | 1 | 2022 | 14 | 0.060 |
Why?
| Antigens, Neoplasm | 1 | 2023 | 170 | 0.050 |
Why?
| Rats, Sprague-Dawley | 2 | 2019 | 1663 | 0.050 |
Why?
| Animals, Newborn | 1 | 2023 | 396 | 0.050 |
Why?
| Fluorescence Polarization | 1 | 2002 | 17 | 0.050 |
Why?
| Adult | 4 | 2022 | 14182 | 0.050 |
Why?
| Organoids | 1 | 2022 | 41 | 0.050 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 74 | 0.050 |
Why?
| Fetus | 2 | 2014 | 227 | 0.050 |
Why?
| Blotting, Western | 2 | 2014 | 683 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 208 | 0.050 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2021 | 36 | 0.050 |
Why?
| Cell Line, Transformed | 1 | 2021 | 88 | 0.050 |
Why?
| Glycolysis | 1 | 2021 | 73 | 0.050 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 51 | 0.050 |
Why?
| Immunity, Cellular | 1 | 2020 | 80 | 0.050 |
Why?
| GTP Phosphohydrolases | 1 | 2020 | 35 | 0.050 |
Why?
| Bacterial Toxins | 1 | 2020 | 61 | 0.050 |
Why?
| Middle Aged | 4 | 2020 | 13070 | 0.050 |
Why?
| Genome, Human | 1 | 2021 | 131 | 0.050 |
Why?
| Metalloendopeptidases | 1 | 2020 | 82 | 0.050 |
Why?
| Biological Transport | 1 | 2020 | 195 | 0.050 |
Why?
| Heat-Shock Response | 1 | 2020 | 29 | 0.050 |
Why?
| Spheroids, Cellular | 1 | 2019 | 26 | 0.050 |
Why?
| Neoplastic Stem Cells | 1 | 2021 | 103 | 0.050 |
Why?
| Cytoprotection | 1 | 2019 | 48 | 0.050 |
Why?
| Radiotherapy | 1 | 2021 | 138 | 0.050 |
Why?
| Databases, Genetic | 1 | 2020 | 101 | 0.040 |
Why?
| Poly(A)-Binding Protein I | 1 | 2019 | 6 | 0.040 |
Why?
| Zonula Occludens-1 Protein | 1 | 2019 | 7 | 0.040 |
Why?
| Oogenesis | 1 | 2019 | 17 | 0.040 |
Why?
| Aquaporin 4 | 1 | 2019 | 9 | 0.040 |
Why?
| Crystallins | 1 | 2019 | 9 | 0.040 |
Why?
| Polyadenylation | 1 | 2019 | 21 | 0.040 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2019 | 37 | 0.040 |
Why?
| Chromatography, Gel | 2 | 2010 | 47 | 0.040 |
Why?
| Eye Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| Trihexosylceramides | 1 | 2018 | 3 | 0.040 |
Why?
| Methyltransferases | 1 | 2018 | 28 | 0.040 |
Why?
| Codon | 1 | 2018 | 48 | 0.040 |
Why?
| Amino Acid Substitution | 2 | 2008 | 105 | 0.040 |
Why?
| Intraocular Pressure | 1 | 2019 | 89 | 0.040 |
Why?
| Actin Cytoskeleton | 1 | 2018 | 26 | 0.040 |
Why?
| Retinal Pigment Epithelium | 1 | 2018 | 24 | 0.040 |
Why?
| Schizosaccharomyces | 1 | 2018 | 53 | 0.040 |
Why?
| Bacteria | 1 | 2020 | 258 | 0.040 |
Why?
| beta Catenin | 1 | 2018 | 102 | 0.040 |
Why?
| Protein Phosphatase 2 | 1 | 2017 | 6 | 0.040 |
Why?
| Transcriptome | 1 | 2020 | 346 | 0.040 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 206 | 0.040 |
Why?
| NFATC Transcription Factors | 1 | 2017 | 20 | 0.040 |
Why?
| Autophagy | 1 | 2019 | 202 | 0.040 |
Why?
| Jurkat Cells | 1 | 2017 | 34 | 0.040 |
Why?
| Mice, Inbred CBA | 1 | 2017 | 39 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2018 | 252 | 0.040 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 88 | 0.040 |
Why?
| Electron Transport Complex III | 1 | 2017 | 12 | 0.040 |
Why?
| Hematopoiesis | 1 | 2017 | 80 | 0.040 |
Why?
| Retinoblastoma-Binding Protein 2 | 1 | 2016 | 6 | 0.040 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 28 | 0.040 |
Why?
| Ribonuclease III | 1 | 2016 | 12 | 0.040 |
Why?
| Species Specificity | 1 | 2017 | 205 | 0.040 |
Why?
| Radiation-Protective Agents | 1 | 2018 | 116 | 0.040 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 45 | 0.040 |
Why?
| Cyclin D1 | 1 | 2016 | 60 | 0.040 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.040 |
Why?
| Oligopeptides | 1 | 2017 | 95 | 0.040 |
Why?
| Detergents | 1 | 2016 | 17 | 0.040 |
Why?
| Electron Transport Complex I | 1 | 2017 | 42 | 0.040 |
Why?
| 14-3-3 Proteins | 1 | 2016 | 24 | 0.040 |
Why?
| tau Proteins | 1 | 2016 | 30 | 0.040 |
Why?
| Thiolester Hydrolases | 1 | 2016 | 7 | 0.040 |
Why?
| DEAD-box RNA Helicases | 1 | 2016 | 35 | 0.040 |
Why?
| Solubility | 1 | 2016 | 75 | 0.040 |
Why?
| Azacitidine | 1 | 2016 | 37 | 0.040 |
Why?
| Cyclophilins | 1 | 2016 | 13 | 0.040 |
Why?
| DNA Copy Number Variations | 1 | 2017 | 114 | 0.040 |
Why?
| X Chromosome | 1 | 2016 | 13 | 0.040 |
Why?
| Operon | 1 | 2016 | 38 | 0.040 |
Why?
| Hydroxylation | 1 | 2016 | 61 | 0.040 |
Why?
| Ubiquitin Thiolesterase | 1 | 2016 | 23 | 0.040 |
Why?
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 16 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2016 | 99 | 0.030 |
Why?
| Ubiquitination | 1 | 2016 | 47 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2016 | 82 | 0.030 |
Why?
| Centrifugation | 1 | 2015 | 15 | 0.030 |
Why?
| Cosmic Radiation | 1 | 2016 | 38 | 0.030 |
Why?
| Osteogenesis Imperfecta | 1 | 2016 | 39 | 0.030 |
Why?
| Endopeptidases | 1 | 2016 | 75 | 0.030 |
Why?
| Protein Interaction Maps | 1 | 2015 | 24 | 0.030 |
Why?
| Tissue Distribution | 1 | 2016 | 178 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2015 | 73 | 0.030 |
Why?
| Myofibroblasts | 1 | 2016 | 48 | 0.030 |
Why?
| Models, Animal | 1 | 2016 | 255 | 0.030 |
Why?
| Cell Death | 1 | 2016 | 223 | 0.030 |
Why?
| Extracellular Matrix | 1 | 2016 | 111 | 0.030 |
Why?
| Isotope Labeling | 1 | 2015 | 58 | 0.030 |
Why?
| Azepines | 1 | 2015 | 22 | 0.030 |
Why?
| Reference Values | 1 | 2016 | 354 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 186 | 0.030 |
Why?
| DNA Damage | 1 | 2017 | 357 | 0.030 |
Why?
| Neurodegenerative Diseases | 1 | 2016 | 83 | 0.030 |
Why?
| Micronucleus, Germline | 1 | 2014 | 2 | 0.030 |
Why?
| DNA, Protozoan | 1 | 2014 | 11 | 0.030 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2014 | 7 | 0.030 |
Why?
| Gene Expression | 1 | 2017 | 664 | 0.030 |
Why?
| Genotype | 1 | 2016 | 599 | 0.030 |
Why?
| Monoamine Oxidase | 1 | 2014 | 15 | 0.030 |
Why?
| Triazoles | 1 | 2015 | 120 | 0.030 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1056 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2014 | 68 | 0.030 |
Why?
| Antibody Specificity | 1 | 2013 | 48 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 94 | 0.030 |
Why?
| Plasmids | 1 | 2014 | 180 | 0.030 |
Why?
| Base Sequence | 1 | 2015 | 719 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 283 | 0.030 |
Why?
| Chemistry, Pharmaceutical | 1 | 2013 | 39 | 0.030 |
Why?
| Antibodies | 1 | 2013 | 178 | 0.030 |
Why?
| Animals, Outbred Strains | 1 | 2012 | 13 | 0.030 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2012 | 26 | 0.030 |
Why?
| p300-CBP Transcription Factors | 1 | 2012 | 5 | 0.030 |
Why?
| Thiazoles | 1 | 2013 | 61 | 0.030 |
Why?
| Case-Control Studies | 1 | 2016 | 1228 | 0.030 |
Why?
| COS Cells | 1 | 2012 | 78 | 0.030 |
Why?
| Lung | 1 | 2016 | 507 | 0.030 |
Why?
| Acid Anhydride Hydrolases | 1 | 2012 | 14 | 0.030 |
Why?
| Catalytic Domain | 1 | 2012 | 62 | 0.030 |
Why?
| Sequence Deletion | 1 | 2012 | 99 | 0.030 |
Why?
| Daptomycin | 1 | 2012 | 33 | 0.030 |
Why?
| Catheter-Related Infections | 1 | 2012 | 55 | 0.030 |
Why?
| Age Factors | 1 | 2016 | 1195 | 0.030 |
Why?
| Drug Design | 1 | 2013 | 133 | 0.030 |
Why?
| Bone and Bones | 1 | 2016 | 516 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2012 | 151 | 0.030 |
Why?
| DNA, Neoplasm | 1 | 2012 | 171 | 0.030 |
Why?
| Arkansas | 1 | 2018 | 2094 | 0.030 |
Why?
| Microbial Sensitivity Tests | 1 | 2012 | 290 | 0.030 |
Why?
| Bacteremia | 1 | 2012 | 101 | 0.030 |
Why?
| Aged | 2 | 2016 | 10041 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 673 | 0.020 |
Why?
| S Phase | 1 | 2010 | 19 | 0.020 |
Why?
| Glycogen Phosphorylase | 1 | 2010 | 2 | 0.020 |
Why?
| Genes, Fungal | 1 | 2010 | 39 | 0.020 |
Why?
| Adenosine Diphosphate | 1 | 2010 | 23 | 0.020 |
Why?
| Oligosaccharides | 1 | 2010 | 45 | 0.020 |
Why?
| Molecular Conformation | 1 | 2009 | 73 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 28 | 0.020 |
Why?
| Rabbits | 1 | 2010 | 425 | 0.020 |
Why?
| RNA, Double-Stranded | 1 | 2008 | 21 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3429 | 0.020 |
Why?
| Tubulin Modulators | 1 | 2008 | 40 | 0.020 |
Why?
| Vincristine | 1 | 2008 | 98 | 0.020 |
Why?
| Cohort Studies | 1 | 2013 | 1543 | 0.020 |
Why?
| Nucleic Acid Denaturation | 1 | 2008 | 14 | 0.020 |
Why?
| Scattering, Radiation | 1 | 2008 | 31 | 0.020 |
Why?
| Cross-Linking Reagents | 1 | 2008 | 42 | 0.020 |
Why?
| Catalysis | 1 | 2008 | 98 | 0.020 |
Why?
| Light | 1 | 2008 | 82 | 0.020 |
Why?
| Photoaffinity Labels | 1 | 2006 | 15 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 34 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2013 | 847 | 0.020 |
Why?
| Peptide Initiation Factors | 1 | 2006 | 3 | 0.020 |
Why?
| HMGB2 Protein | 1 | 2006 | 2 | 0.020 |
Why?
| Acetyl Coenzyme A | 1 | 2006 | 8 | 0.020 |
Why?
| Antigens, Nuclear | 1 | 2006 | 24 | 0.020 |
Why?
| RNA Polymerase II | 1 | 2006 | 17 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 820 | 0.020 |
Why?
| Xenopus | 1 | 2006 | 47 | 0.020 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2005 | 17 | 0.020 |
Why?
| Enzyme Activation | 1 | 2006 | 329 | 0.020 |
Why?
| Telomere | 1 | 2005 | 36 | 0.020 |
Why?
| Microarray Analysis | 1 | 2005 | 84 | 0.020 |
Why?
| Zinc Fingers | 1 | 2005 | 21 | 0.020 |
Why?
| Myeloid-Lymphoid Leukemia Protein | 1 | 2005 | 16 | 0.020 |
Why?
| Multienzyme Complexes | 1 | 2005 | 41 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2005 | 47 | 0.020 |
Why?
| Computer Simulation | 1 | 2006 | 332 | 0.020 |
Why?
| Pregnancy | 1 | 2012 | 2620 | 0.020 |
Why?
| Amino Acids | 1 | 2006 | 369 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2006 | 923 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2003 | 1 | 0.010 |
Why?
| Cyclin B | 1 | 2003 | 6 | 0.010 |
Why?
|
|
Tackett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|